Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 11.1456 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 11.7225 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 11.2998 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 11.3084 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 12.2619 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 11.5621 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 11.4872 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 11.7986 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 11.2862 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 11.4199 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 11.2684 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 11.6758 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 10.9753 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 11.6856 | 99 |